Announcement:
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma
News Release:
Generate:Biomedicines welcomes Aarif Khakoo, MD, MBA, as chief scientific officer
Get the latest updates from our team on new research, thought leadership, and company news and events.